Meinian Onehealth Launches AI Innovation and Entrepreneurship Competition to Accelerate AIGC and Large Model Strategy in Healthcare

VCBeat has learned that Meinian Onehealth, a leading enterprise in the field of preventive healthcare, has recently made another significant move by hosting the 12th China Innovation and Entrepreneurship Competition—“AI Big Data Medical Health Professional Competition.” The company is publicly seeking partners in the fields of AIGC and large language models, once again demonstrating its strategic commitment to going “All-in on Digitalization.” It is understood that registration for the Meinian Onehealth AI Big Data Medical Health Professional Competition has already opened. Participating teams can register via the official website of the China Innovation and Entrepreneurship Competition (mndjk.cxcyds.com), with a deadline of October 11.

The China Innovation and Entrepreneurship Competition is the most authoritative and influential national-level competition in China, jointly guided by the Ministry of Science and Technology, the Ministry of Finance, the Ministry of Education, the Cyberspace Administration of China, and the All-China Federation of Industry and Commerce. Since the inaugural competition was held in 2012, it has attracted over 320,000 participating enterprises and teams over the past 12 years, leveraging more than RMB 100 billion in financial capital from banks and venture capital firms to invest in participating companies. Among all participants across previous editions, more than 200 enterprises have successfully gone public. The Professional Track, an important component of the China Innovation and Entrepreneurship Competition, focuses on cultivating emerging industries and future industries, promotes integrated development among large, medium-sized, and small enterprises, and guides leading enterprises and social capital to support technological micro, small, and medium-sized enterprises (MSMEs) in carrying out key industrial technological innovations.

Regarding the original intention behind hosting this AI and Big Data professional competition, Meinian Onehealth Healthcare Group stated that the AIGC technological revolution, represented by ChatGPT, is unstoppable. Large language models have become a strategic opportunity for driving economic growth, and various industries are reaching a turning point characterized by AI-driven new technologies and paradigm shifts. As a leading enterprise in the field of preventive healthcare, Meinian Onehealth is actively embracing the era of large language models and firmly implementing its “All-in on Digitalization” strategy. Through this professional competition, the company aims to identify partners in the fields of AIGC and large language models, comprehensively promote the deployment of these technologies in business scenarios, jointly build a new ecosystem for the healthcare AIGC industry, and lead the comprehensive digital transformation of the health checkup industry towards digital health management.

It is reported that the professional competition will invite renowned investors from top-tier investment firms and AI experts to serve as judges. The winning teams will have the opportunity to receive venture capital investment from Meinian Onehealth Healthcare Group, as well as gain access to its vast health examination data resources and application scenarios across more than 600 examination centers.

In the book *GPT for Medicine: Beyond Imagination*, Peter Lee, head of Microsoft Research, shares the boundless possibilities that large models represented by GPT-4 will bring to the field of medical health. However, compared with vertical industries such as media, marketing, and law, the implementation and application of large models in the medical and healthcare sector lag far behind. A key reason for this is that technical teams developing large models struggle to access medical and healthcare-related corpora and datasets, as well as to conduct testing and fine-tuning in real-world business environments.

Meinian Onehealth is a leading enterprise in the field of preventive healthcare, possessing the largest health checkup big data resources in China. Its network of over 600 centers nationwide serves 30 million person-visits annually. Since its listing in 2015, the company has cumulatively served nearly 200 million person-visits. Furthermore, Meinian Group jointly established the Peking University-Meinian Institute of Public Health with the Health Science Center of Peking University. This institute employs cutting-edge international methods and technologies to govern, analyze, and apply these data, creating a multimodal database that encompasses various data types, including scales, text, imaging, waveforms, and omics. In April 2023, Meinian Onehealth and the Peking University-Meinian Institute of Public Health jointly released the "Meinian Onehealth 2022 Annual Health Checkup Big Data Blue Book." The Blue Book analyzed a sample size of 16.47 million person-visits, covering all 31 provinces, autonomous regions, and municipalities directly under the Central Government in China. It is the first report of its kind domestically to feature a sample size exceeding ten million, the widest geographic coverage, and an analysis of health checkup data from a multi-ethnic healthy population. Industry experts note that the continuously growing massive data scale and diverse data types of Meinian Onehealth Group constitute a "rich mine" of health data, providing irreplicable data conditions for the development of large industry models.

In addition to its vast repository of industry data, Meinian Onehealth boasts a professional team of over 60,000 medical, nursing, and management personnel. Leveraging more than two decades of expertise in preventive healthcare, Meinian Onehealth will provide rich domain knowledge and expert-led manual annotation for critical stages in the development of large industry-specific models, including prompt engineering, supervised fine-tuning, and reinforcement learning. Furthermore, it will conduct testing and optimization of these large models within real-world business scenarios. These efforts will significantly accelerate the practical implementation of AIGC and large model technologies in the healthcare sector.

Industrial scenarios serve as the proving ground for large model applications. Meinian Health will open up a wealth of business scenarios for large model deployment by covering the entire health examination process—pre-examination, during examination, and post-examination—as well as a series of value-added services including post-examination specialist care, genetic testing, chronic disease management, and health insurance. Building on the powerful general capabilities of large models, the company integrates general medical practice with Meinian’s proprietary industry knowledge and experience to leverage AI in reengineering business processes and service experiences.

For health checkup clients, Meinian plans to develop and introduce products and services such as AI health consultation, AI interpretation of health checkup reports, AI health insurance, AI mental health companionship, and AI virtual health managers, comprehensively enhancing service quality and customer experience. This initiative aims to meet customers’ holistic, full-lifecycle health management needs and establish a new paradigm for digital health management in the era of large language models. For internal employees, Meinian will develop and introduce a series of AI productivity tools, creating an AI co-pilot system for teams including sales, customer service, chief examining physicians, and health managers, thereby driving cost reduction and efficiency improvements for both Meinian and the entire health checkup industry.

Centered on the innovative demands of the aforementioned application scenarios, this competition features multiple specialized tracks and challenge categories. For instance, one track is titled “Development of an Intelligent Chief Examiner System Based on Large Model Technology.” Participating teams will leverage de-identified health examination datasets to develop domain-specific large language models and design the system architecture for an AI co-pilot, addressing the specific requirements and pain points associated with drafting chief examiner reports. Winning teams will have the opportunity to collaborate with Meinian on jointly building an intelligent chief examiner system powered by large model technology.

It is reported that to accelerate the strategic implementation of AIGC and large language models, Meinian Onehealth will engage in ecosystem collaboration with industry partners and innovative teams across computing power, model technology, and application layers through a “1+1+N” cooperation model. In addition to opening up N application scenarios, Meinian Onehealth will complete the construction of a series of critical infrastructure and middleware components. This initiative aims to provide healthcare institutions and enterprises with industry-specific large model capabilities, high-quality training datasets, and instruction sets, thereby accelerating the digital and intelligent transformation of the entire sector and demonstrating the mission and responsibility of a leading industry player. Further details will be announced at an appropriate time.

In addition to diversifying its collaboration models, Meinian Onehealth will facilitate industry-finance integration and provide multifaceted support to its partners. According to Meinian Onehealth Group, the company has successfully hosted four editions of the China Innovation and Entrepreneurship Competition—Special Track for Integration of Large, Medium, Small, and Micro Enterprises, focusing on intelligent precision medicine, proactive health, and digital healthcare, and has served more than 1,000 enterprises and teams to date. This year’s competition centers on innovative applications of AIGC in the healthcare industry and the development of AI-powered chief examiner systems based on large health management models. It organizes project evaluations and service activities aimed at strengthening industry-finance linkages and enhancing financial support for technology-driven enterprises. To date, financial and professional service institutions such as SDIC High-Tech Investment Corporation, CICC Capital, Mercer Consulting, Tianyuan Law Firm, Haitong Securities, Gaohua Securities, United Capital Partners, Tsinghua Holdings Ginkgo, Qingsong Capital, Puhua Capital, Boyuan Capital, Qiming Venture Partners, Fortune Capital, Cowin Capital, CSC Financial Capital, and CMB International Capital have been invited to participate in project evaluations, roadshows, and other investment and financing activities associated with the competition.

Furthermore, this professional competition is jointly hosted by the National SME Science and Technology Innovation Foundation, Health Intelligence Valley, and VCBeat. As one of the organizing entities for the China Innovation and Entrepreneurship Competition, the National SME Science and Technology Innovation Foundation is committed to channeling innovation resources toward enterprises as the primary drivers of technological innovation, thereby empowering corporate technological advancement and the commercialization of research outcomes. Health Intelligence Valley is a leading domestic healthcare innovation enablement platform and science park operator. VCBeat is a premier healthcare industry research institution and media platform in China. Together, these three organizations will provide participating companies and teams with specialized services—including technology incubation, market expansion, capital matchmaking, data validation, promotional support, and industry analysis—tailored to the industrial ecosystem of Meinian Onehealth Healthcare Group.

Meinian Onehealth Healthcare Group stated that it looks forward to the active participation of various innovative entities in this Innovation and Entrepreneurship Competition, to seize the critical moment for industrial upgrading, jointly promote the practical application of AIGC and large model technologies in the healthcare industry, work together to build new applications and business models within the healthcare AIGC ecosystem, and leverage technological innovation as a powerful driver for the “Healthy China” initiative.